Pantelis Nicola

机构：Wellcome Sanger Institute · ORCID：0000-0002-8641-3580

发表论文 30 篇 · 总被引 2073 次 · h-index 10

代表论文

• Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021 · The Lancet · 被引 564)
• Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial (2021 · The Lancet · 被引 523)
• Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2022 · The Lancet · 被引 384)
• Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021 · The Lancet · 被引 292)
• Mechanisms of Resistance to KRASG12C Inhibitors (2021 · Cancers · 被引 121)
• Somatic mutation and selection at population scale (2025 · Nature · 被引 42)